High-Dose Ibuprofen, COX-2s Show Similar Vascular Event Risk, BMJ Study Says
This article was originally published in The Pink Sheet Daily
Researchers found no significant difference in vascular events between COX-2s, NSAIDs overall in British Medical Journal report.
You may also be interested in...
Advisory follows recent JAMA study finding that maximum recommended OTC intake resulted in elevated liver enzymes for some participants.
Worldwide Sport Nutritional Supplements' use of the claim "America's Decided! We're Number One!" for its Pure Power Protein Bars is "flawed" and unsubstantiated, the National Advertising Division states in an upcoming issue of Case Reports
The Natural Products Association is expanding testing in its TruLabel verification program to assure consumers that the products "are without traces of banned steroidal and stimulant ingredients.